These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 11595988

  • 1. Relapse in persons treated for drug-susceptible tuberculosis in a population with high coinfection with human immunodeficiency virus in New York City.
    Driver CR, Munsiff SS, Li J, Kundamal N, Osahan SS.
    Clin Infect Dis; 2001 Nov 15; 33(10):1762-9. PubMed ID: 11595988
    [Abstract] [Full Text] [Related]

  • 2. Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.
    Li J, Munsiff SS, Driver CR, Sackoff J.
    Clin Infect Dis; 2005 Jul 01; 41(1):83-91. PubMed ID: 15937767
    [Abstract] [Full Text] [Related]

  • 3. The impact of human immunodeficiency virus on response to treatment and recurrence rate in patients treated for tuberculosis: two-year follow-up of a cohort in Lusaka, Zambia.
    Elliott AM, Halwiindi B, Hayes RJ, Luo N, Mwinga AG, Tembo G, Machiels L, Steenbergen G, Pobee JO, Nunn PP.
    J Trop Med Hyg; 1995 Feb 01; 98(1):9-21. PubMed ID: 7861484
    [Abstract] [Full Text] [Related]

  • 4. Risk factors and outcome of human immunodeficiency virus-infected patients with sporadic multidrug-resistant tuberculosis in New York City.
    Mannheimer SB, Sepkowitz KA, Stoeckle M, Friedman CR, Hafner A, Riley LW.
    Int J Tuberc Lung Dis; 1997 Aug 01; 1(4):319-25. PubMed ID: 9432387
    [Abstract] [Full Text] [Related]

  • 5. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.
    Kekkaku; 2003 Oct 01; 78(10):611-7. PubMed ID: 14621568
    [Abstract] [Full Text] [Related]

  • 6. Influence of the human immunodeficiency virus in the incidence of tuberculosis in a cohort of intravenous drug users: effectiveness of anti-tuberculosis chemoprophylaxis.
    Jansà JM, Serrano J, Caylà JA, Vidal R, Ocaña I, Español T.
    Int J Tuberc Lung Dis; 1998 Feb 01; 2(2):140-6. PubMed ID: 9580481
    [Abstract] [Full Text] [Related]

  • 7. A continuing survey of drug-resistant tuberculosis, New York City, April 1994.
    Fujiwara PI, Cook SV, Rutherford CM, Crawford JT, Glickman SE, Kreiswirth BN, Sachdev PS, Osahan SS, Ebrahimzadeh A, Frieden TR.
    Arch Intern Med; 1997 Mar 10; 157(5):531-6. PubMed ID: 9066457
    [Abstract] [Full Text] [Related]

  • 8. Isoniazid preventive therapy in human immunodeficiency virus-infected persons. Long-term effect on development of tuberculosis and survival.
    Moreno S, Miralles P, Diaz MD, Baraia J, Padilla B, Berenguer J, Alberdi JC.
    Arch Intern Med; 1997 Mar 10; 157(15):1729-34. PubMed ID: 9250234
    [Abstract] [Full Text] [Related]

  • 9. Relapse of tuberculosis after treatment in human immunodeficiency virus-infected patients.
    Pulido F, Peña JM, Rubio R, Moreno S, González J, Guijarro C, Costa JR, Vázquez JJ.
    Arch Intern Med; 1997 Jan 27; 157(2):227-32. PubMed ID: 9009982
    [Abstract] [Full Text] [Related]

  • 10. Impact of HIV infection on the recurrence of tuberculosis in South India.
    Narayanan S, Swaminathan S, Supply P, Shanmugam S, Narendran G, Hari L, Ramachandran R, Locht C, Jawahar MS, Narayanan PR.
    J Infect Dis; 2010 Mar 27; 201(5):691-703. PubMed ID: 20121433
    [Abstract] [Full Text] [Related]

  • 11. Virological response to highly active antiretroviral therapy is unaffected by antituberculosis therapy.
    Breen RA, Miller RF, Gorsuch T, Smith CJ, Ainsworth J, Ballinger J, Swaden L, Cropley I, Johnson MA, Lipman MC.
    J Infect Dis; 2006 May 15; 193(10):1437-40. PubMed ID: 16619192
    [Abstract] [Full Text] [Related]

  • 12. Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampin-based treatment: an analytical review.
    Korenromp EL, Scano F, Williams BG, Dye C, Nunn P.
    Clin Infect Dis; 2003 Jul 01; 37(1):101-12. PubMed ID: 12830415
    [Abstract] [Full Text] [Related]

  • 13. Treatment outcome of relapse and defaulter pulmonary tuberculosis patients.
    Sevim T, Ataç G, Güngör G, Törün I, Aksoy E, Gemci, Tahaoglu K.
    Int J Tuberc Lung Dis; 2002 Apr 01; 6(4):320-5. PubMed ID: 11936741
    [Abstract] [Full Text] [Related]

  • 14. Trends in drug-resistant Mycobacterium tuberculosis in New York City, 1991-2003.
    Munsiff SS, Li J, Cook SV, Piatek A, Laraque F, Ebrahimzadeh A, Fujiwara PI.
    Clin Infect Dis; 2006 Jun 15; 42(12):1702-10. PubMed ID: 16705575
    [Abstract] [Full Text] [Related]

  • 15. Treatment outcomes by drug resistance and HIV status among tuberculosis patients in Ho Chi Minh City, Vietnam.
    Quy HT, Cobelens FG, Lan NT, Buu TN, Lambregts CS, Borgdorff MW.
    Int J Tuberc Lung Dis; 2006 Jan 15; 10(1):45-51. PubMed ID: 16466036
    [Abstract] [Full Text] [Related]

  • 16. Pattern of active pulmonary tuberculosis in human immunodeficiency virus seropositive adult patients in University College Hospital, Ibadan, Nigeria.
    Awoyemi OB, Ige OM, Onadeko BO.
    Afr J Med Med Sci; 2002 Mar 15; 31(1):25-31. PubMed ID: 12518925
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of acquired MDR-TB and HIV co-infection.
    Deivanayagam CN, Rajasekaran S, Venkatesan R, Mahilmaran A, Ahmed PR, Annadurai S, Kumar S, Chandrasekar C, Ravichandran N, Pencillaiah R.
    Indian J Chest Dis Allied Sci; 2002 Mar 15; 44(4):237-42. PubMed ID: 12437236
    [Abstract] [Full Text] [Related]

  • 18. Factors associated with treatment outcomes in pulmonary tuberculosis in northeastern Thailand.
    Anunnatsiri S, Chetchotisakd P, Wanke C.
    Southeast Asian J Trop Med Public Health; 2005 Mar 15; 36(2):324-30. PubMed ID: 15916037
    [Abstract] [Full Text] [Related]

  • 19. Active tuberculosis in individuals infected with human immunodeficiency virus after isoniazid prophylaxis.
    Fitzgerald DW, Morse MM, Pape JW, Johnson WD.
    Clin Infect Dis; 2000 Dec 15; 31(6):1495-7. PubMed ID: 11096020
    [Abstract] [Full Text] [Related]

  • 20. Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy.
    Swaminathan S, Deivanayagam CN, Rajasekaran S, Venkatesan P, Padmapriyadarsini C, Menon PA, Ponnuraja C, Dilip M.
    Natl Med J India; 2008 Dec 15; 21(1):3-8. PubMed ID: 18472696
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.